BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5129.95B
Enterprise Value 3159.22B
Trailing P/E 111.95
Forward P/E 17.74
PEG Ratio (5 yr expected) 10.43
Price/Sales (ttm)4.19
Price/Book (mrq)2.60
Enterprise Value/Revenue 35.14
Enterprise Value/EBITDA 613.75

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 329.96%
S&P500 52-Week Change 35.66%
52 Week High 368.34
52 Week Low 342.48
50-Day Moving Average 358.81
200-Day Moving Average 360.50

Share Statistics

Avg Vol (3 month) 315.69M
Avg Vol (10 day) 310.83M
Shares Outstanding 52.26B
Float 2.26B
% Held by Insiders 10.11%
% Held by Institutions 179.09%
Shares Short (Jun. 14, 2020) 430.59M
Short Ratio (Jun. 14, 2020) 41.88
Short % of Float (Jun. 14, 2020) 41.35%
Short % of Shares Outstanding (Jun. 14, 2020) 41.35%
Shares Short (prior month May 14, 2020) 434.43M

Dividends & Splits

Forward Annual Dividend Rate 41.8
Forward Annual Dividend Yield 43.10%
Trailing Annual Dividend Rate 31.72
Trailing Annual Dividend Yield 32.96%
5 Year Average Dividend Yield 42.74
Payout Ratio 4273.02%
Dividend Date 3Aug. 02, 2020
Ex-Dividend Date 4Jul. 01, 2020
Last Split Factor 21000000:951777
Last Split Date 3Aug. 06, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 3.08%
Operating Margin (ttm)24.63%

Management Effectiveness

Return on Assets (ttm)5.82%
Return on Equity (ttm)3.00%

Income Statement

Revenue (ttm)31.01B
Revenue Per Share (ttm)16.66
Quarterly Revenue Growth (yoy)82.10%
Gross Profit (ttm)18.93B
EBITDA 11.58B
Net Income Avi to Common (ttm)954M
Diluted EPS (ttm)0.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.32B
Total Cash Per Share (mrq)8.1
Total Debt (mrq)47.53B
Total Debt/Equity (mrq)95.10
Current Ratio (mrq)1.66
Book Value Per Share (mrq)22.06

Cash Flow Statement

Operating Cash Flow (ttm)10.57B
Levered Free Cash Flow (ttm)9.5B